Collegium Pharmaceutical Inc
collegiumpharma.comCollegium Pharmaceutical (NASDAQ: COLL) is a specialty pharmaceutical company that commercializes branded pain management medications. Revenue is generated through net product sales of its prescription drug portfolio to wholesalers, specialty distributors, and pharmacy benefit managers. The 10-K filed 2026-02-26 (accession 0001628280-26-011992) confirms Collegium operates as a commercial-stage specialty pharma business focused on pain and central nervous system conditions. The company's shares are listed on the Nasdaq Global Select Market with a par value of $0.001 per share.
Products & Services
Branded prescription pain management and central nervous system medications. Specific product names are not confirmed by the available filing excerpts.
Revenue Model
Net product sales of branded prescription medications sold through pharmaceutical wholesalers, specialty distributors, and pharmacy channels.
Customers & Markets
Wholesalers, specialty distributors, and pharmacy benefit managers serving the prescription pain management market. Specific customer concentration figures are not supported by the available excerpts.
Geographic Exposure
United States. Geographic mix beyond domestic operations is not supported by the available filing excerpts.
Loading...
